CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 21 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $351,000 | -23.9% | 909,453 | -1.4% | 0.00% | – |
| Q4 2015 | $461,000 | -99.7% | 921,934 | -85.1% | 0.00% | -100.0% |
| Q3 2015 | $156,921,000 | +22253.4% | 6,177,466 | +604.6% | 0.01% | – |
| Q2 2015 | $702,000 | -4.9% | 876,777 | +7.0% | 0.00% | – |
| Q1 2015 | $738,000 | +55.4% | 819,612 | +20.7% | 0.00% | – |
| Q4 2014 | $475,000 | -76.0% | 679,160 | +4.2% | 0.00% | – |
| Q3 2014 | $1,981,000 | +1.3% | 651,660 | +2.3% | 0.00% | – |
| Q2 2014 | $1,956,000 | -11.6% | 637,190 | +6.0% | 0.00% | – |
| Q1 2014 | $2,212,000 | -0.6% | 601,190 | +8.6% | 0.00% | – |
| Q4 2013 | $2,226,000 | -4.0% | 553,691 | +2.0% | 0.00% | – |
| Q3 2013 | $2,318,000 | +126.8% | 542,759 | +56.7% | 0.00% | – |
| Q2 2013 | $1,022,000 | – | 346,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 250,000 | $920,000 | 0.42% |
| Rotella Capital Management, Inc. | 19,639 | $72,000 | 0.09% |
| Invesco Private Capital | 116,316 | $428,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 26,500 | $97,000 | 0.01% |
| Allianz Asset Management GmbH | 559,207 | $2,058,000 | 0.00% |
| North Star Investment Management Corp. | 1,857 | $7,000 | 0.00% |
| UBS AG | 1,000 | $4,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 4,300 | $16,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 26,712 | $98,000 | 0.00% |
| NORTHERN TRUST CORP | 32,991 | $121,000 | 0.00% |